Cargando…
Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee inta...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306703/ https://www.ncbi.nlm.nih.gov/pubmed/35001424 http://dx.doi.org/10.1002/mds.28897 |
_version_ | 1784752600060526592 |
---|---|
author | Ishibashi, Kenji Miura, Yoshiharu Wagatsuma, Kei Toyohara, Jun Ishiwata, Kiichi Ishii, Kenji |
author_facet | Ishibashi, Kenji Miura, Yoshiharu Wagatsuma, Kei Toyohara, Jun Ishiwata, Kiichi Ishii, Kenji |
author_sort | Ishibashi, Kenji |
collection | PubMed |
description | BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee intake in PD. METHODS: Five patients with PD underwent (11)C‐preladenant positron emission tomography scanning at baseline and after intake of coffee containing 129.5 mg (n = 3) or 259 mg (n = 2) of caffeine. Concurrently, serum caffeine levels were measured. RESULTS: The mean serum caffeine level (μg/mL) was 0.374 at baseline and increased to 4.48 and 8.92 by 129.5 and 259 mg of caffeine, respectively. The mean occupancy rates of striatal A(2A)Rs by 129.5 and 259 mg of caffeine were 54.2% and 65.1%, respectively. CONCLUSIONS: A sufficient A(2A)R occupancy can be obtained by drinking a cup of coffee, which is equivalent to approximately 100 mg of caffeine. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. |
format | Online Article Text |
id | pubmed-9306703 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93067032022-07-28 Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease Ishibashi, Kenji Miura, Yoshiharu Wagatsuma, Kei Toyohara, Jun Ishiwata, Kiichi Ishii, Kenji Mov Disord Regular Issue Articles BACKGROUND: Coffee intake can decrease the risk for Parkinson's disease (PD). Its beneficial effects are allegedly mediated by caffeine through adenosine A(2A) receptor (A(2A)R) antagonist action. OBJECTIVE: We aimed to calculate occupancy rates of striatal A(2A)Rs by caffeine after coffee intake in PD. METHODS: Five patients with PD underwent (11)C‐preladenant positron emission tomography scanning at baseline and after intake of coffee containing 129.5 mg (n = 3) or 259 mg (n = 2) of caffeine. Concurrently, serum caffeine levels were measured. RESULTS: The mean serum caffeine level (μg/mL) was 0.374 at baseline and increased to 4.48 and 8.92 by 129.5 and 259 mg of caffeine, respectively. The mean occupancy rates of striatal A(2A)Rs by 129.5 and 259 mg of caffeine were 54.2% and 65.1%, respectively. CONCLUSIONS: A sufficient A(2A)R occupancy can be obtained by drinking a cup of coffee, which is equivalent to approximately 100 mg of caffeine. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. John Wiley & Sons, Inc. 2022-01-09 2022-04 /pmc/articles/PMC9306703/ /pubmed/35001424 http://dx.doi.org/10.1002/mds.28897 Text en © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regular Issue Articles Ishibashi, Kenji Miura, Yoshiharu Wagatsuma, Kei Toyohara, Jun Ishiwata, Kiichi Ishii, Kenji Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title | Adenosine A(2A)
Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title_full | Adenosine A(2A)
Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title_fullStr | Adenosine A(2A)
Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title_full_unstemmed | Adenosine A(2A)
Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title_short | Adenosine A(2A)
Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease |
title_sort | adenosine a(2a)
receptor occupancy by caffeine after coffee intake in parkinson's disease |
topic | Regular Issue Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306703/ https://www.ncbi.nlm.nih.gov/pubmed/35001424 http://dx.doi.org/10.1002/mds.28897 |
work_keys_str_mv | AT ishibashikenji adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease AT miurayoshiharu adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease AT wagatsumakei adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease AT toyoharajun adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease AT ishiwatakiichi adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease AT ishiikenji adenosinea2areceptoroccupancybycaffeineaftercoffeeintakeinparkinsonsdisease |